Identification, diagnosis, and treatment of breast cancer

Details for Australian Patent Application No. 2001259477 (hide)

Owner CYTYC Corporation

Inventors Hung, David; Nikolchev, Julian; Love, Susan; Cen, Hui

Agent Spruson & Ferguson

Pub. Number AU-B-2001259477

PCT Pub. Number WO01/85219

Priority 09565642 05.05.00 US

Filing date 4 May 2001

Wipo publication date 20 November 2001

Acceptance publication date 16 November 2006

International Classifications

A61K 49/00 (2006.01) Preparations for testing

A61K 49/16 (2006.01) Preparations for testing

A61K 49/18 (2006.01) Preparations for testing

A61K 51/10 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61K 51/12 (2006.01) Preparations containing radioactive substances for use in therapy or testing - characterised by a special physical form, e.g. emulsion, microcapsules, liposomes

Event Publications

18 March 2004 Assignment before Grant

  Pro Duct Health, Inc. The application has been assigned to CYTYC Corporation

16 November 2006 Application Accepted

  Published as AU-B-2001259477

15 March 2007 Standard Patent Sealed

20 March 2008 Assignment Registered

  CYTYC Corporation ( Goldman Sachs Credit Partners LP )

6 January 2011 Licence Registered

  Discharge of a Mortgage was made in the Register on 15.09.2010.

29 March 2012 Assignment Registered

  CYTYC Corporation The patent has been assigned to Atossa Genetics, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001259478

2001259476